Inmode Ltd [INMD] stock is trading at $21.99, up 2.57%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The INMD shares have gain 4.86% over the last week, with a monthly amount drifted -5.42%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 13, February 2024, InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M. In a post published today on Yahoo Finance, InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year ended December 31, 2023.
From an analyst’s perspective:
Inmode Ltd [NASDAQ: INMD] stock has seen the most recent analyst activity on November 03, 2023, when UBS downgraded its rating to a Neutral and also revised its price target to $24 from $52. Previously, Canaccord Genuity downgraded its rating to Hold on October 13, 2023, and dropped its price target to $22. On March 29, 2023, UBS initiated with a Buy rating and assigned a price target of $40 on the stock. Needham downgraded its rating to a Hold. Barclays initiated its recommendation with a Overweight and recommended $44 as its price target on December 21, 2022. Jefferies started tracking with a Buy rating for this stock on October 12, 2022, and assigned it a price target of $40. In a note dated May 25, 2021, Barclays initiated an Overweight rating and provided a target price of $92 on this stock.
Inmode Ltd [INMD] stock has fluctuated between $18.57 and $48.25 over the past year. Currently, Wall Street analysts expect the stock to reach $53.5 within the next 12 months. Inmode Ltd [NASDAQ: INMD] shares were valued at $21.99 at the most recent close of the market. An investor can expect a potential return of 143.29% based on the average INMD price forecast.
Analyzing the INMD fundamentals
Inmode Ltd [NASDAQ:INMD] reported sales of 492.05M for the trailing twelve months, which represents a drop of -5.08%. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.53 points at the first support level, and at 21.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.28, and for the 2nd resistance point, it is at 22.57.
Ratios To Look Out For
For context, Inmode Ltd’s Current Ratio is 13.18. As well, the Quick Ratio is 12.29, while the Cash Ratio is 0.05. Considering the valuation of this stock, the price to sales ratio is 3.77, the price to book ratio is 2.35 and price to earnings (TTM) ratio is 9.52.
